Your session is about to expire
← Back to Search
Telephone Support for Postpartum Depression
N/A
Waitlist Available
Led By Sylvana Côté
Research Sponsored by St. Justine's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Pregnant women (12-25 weeks' gestation)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (between gestational weeks 12-25) , 3 and 6 months postpartum
Awards & highlights
Study Summary
This trial will compare an online/telephone parenting course to the same course without telephone support, in order to evaluate the effectiveness of the intervention in improving mental health outcomes for parents.
Who is the study for?
This trial is for French-speaking pregnant women between 12-25 weeks' gestation who are at risk of postpartum depression, with mild to moderate depressive symptoms. Women with severe depression, psychosis, or substance abuse issues cannot participate.Check my eligibility
What is being tested?
The study tests the Parents & Babies program's effectiveness in preventing postpartum depression when accompanied by telephone support versus without it. The intervention includes a distance learning course during pregnancy.See study design
What are the potential side effects?
Since this trial involves educational material and phone support rather than medication, there are no typical drug side effects; however, participants may experience emotional discomfort discussing personal topics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am pregnant and between 12 to 25 weeks along.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (between gestational weeks 12-25) , 3 and 6 months postpartum
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (between gestational weeks 12-25) , 3 and 6 months postpartum
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline at 3 month postpartum depressive symptoms: The Edinburgh Perinatal/Postnatal Depression Scale (EPDS)
Secondary outcome measures
Anxiety related to pregnancy: Pregnancy-specific anxiety scale (PRAQ-R2)
Change from 3 months post-partum at 6 month post partum child social, emotional and cognitive development: Ages and stages questionnaire 3rd edition (ASQ-3)
Change from baseline in Generalized Anxiety Disorder questionnaire (GAD-7) score
+14 moreOther outcome measures
Health Service Utilization and Cost of Care Questionnaire
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive-Behavioral Therapy (CBT) and interpersonal counseling with telephone support.Experimental Treatment1 Intervention
The experimental group will receive an online cognitive behavioural intervention with weekly telephone support
Group II: Access to an online cognitive behavioural intervention without telephone supportActive Control1 Intervention
The control group will receive a fully automated version of the virtual intervention without telephone support
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telephone support
2015
N/A
~30
Find a Location
Who is running the clinical trial?
Hewitt FoundationUNKNOWN
1 Previous Clinical Trials
1,238 Total Patients Enrolled
Canadian Medical AssociationUNKNOWN
St. Justine FoundationUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am pregnant and between 12 to 25 weeks along.My depression score is between 8 and 16.My depression score is either high (17 or above) or very low (below 8).I can read and understand French.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive-Behavioral Therapy (CBT) and interpersonal counseling with telephone support.
- Group 2: Access to an online cognitive behavioural intervention without telephone support
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger